Home / Market News / $STE
fiscal.ai Corporate Catalyst Impact 65/100 ● neutral

Analysts Adjust Price Targets for STERIS

Nov 6, 2026, 7:08 PM UTC · Primary ticker $STE

Several financial analysts, including UBS and Stephens, have raised their price targets for STERIS plc following the company's second-quarter fiscal 2027 financial results. This indicates a positive sentiment from these firms regarding STERIS's recent performance and future prospects, potentially leading to increased investor interest.

UBS and Stephens both increased their price targets for STERIS plc to $290 from $270, with UBS reiterating a Buy rating, and Keybanc maintaining an Overweight rating. These actions directly follow STERIS's recent reporting of its second-quarter fiscal 2027 financial results. This matters because analyst upgrades and price target increases often signal improved financial outlooks and can positively influence investor perception and stock performance in the short term. The primary entity affected is STERIS, as these analyst actions reflect confidence in its recent financial performance. For traders, this presents a potential short-term opportunity for upward momentum, though long-term implications depend on sustained financial performance and broader market conditions. A key risk is that the market may have already priced in these expectations, or that future results could disappoint.

$STE positive Analyst price target increases and maintained ratings
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.